First GPR119 PET Imaging Ligand: Synthesis, Radiochemistry, and Preliminary Evaluations
Journal of Medicinal Chemistry · 13.07.2023 · 66 (13) · 9120-9129
DOI: 10.1021/acs.jmedchem.3c00720 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 14.06.2023. Verfasst von Avinash H Bansode und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Wake Forest School of Medicine, Winston-Salem, North Carolina 27157, United States. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NCATS NIH HHS, National Center for Advancing Translational Sciences.
Abstract (Originalsprache)
G-protein-coupled receptor 119 (GPR119) has emerged as a promising target for treating type 2 diabetes mellitus. Activating GPR119 improves glucose homeostasis, while suppressing appetite and weight gain. Measuring GPR119 levels in vivo could significantly advance GPR119-based drug development strategies including target engagement, occupancy, and distribution studies. To date, no positron emission tomography (PET) ligands are available to image GPR119. In this paper, we report the synthesis, radiolabeling, and preliminary biological evaluations of a novel PET radiotracer [18F]KSS3 to image GPR119. PET imaging will provide information on GPR119 changes with diabetic glycemic loads and the efficacy of GPR119 agonists as antidiabetic drugs. Our results demonstrate [18F]KSS3's high radiochemical purity, specific activity, cellular uptake, and in vivo and ex vivo uptake in pancreas, liver, and gut regions, with high GPR119 expression. Cell pretreatment with nonradioactive KSS3, rodent PET imaging, biodistribution, and autoradiography studies showed significant blocking in the pancreas showing [18F]KSS3's high specificity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Wake Forest School of Medicine, Winston-Salem, North Carolina 27157, United States.
- Department of Chemistry, Koneru Lakshmaiah Education Foundation, Vijayawada, 522302 Andhra Pradesh, India.
- Department of Endocrinology, Wake Forest School of Medicine, Winston Salem, North Carolina 27157, United States.
- Department of Internal Medicine-Gerontology and Geriatric Medicine, Wake Forest School of Medicine, Winston Salem, North Carolina 27157, United States.
- Department of Comparative Medicine, Wake Forest School of Medicine, Winston Salem, North Carolina 27157, United States.
ORCID-Profile: Bhuvanachandra Bhoopal, Kiran Kumar Solingapuram Sai
Förderung
- NIH HHS
- NCATS NIH HHS
- National Center for Advancing Translational Sciences
- NIH Office of the Director
Zitieren
APA
Bansode, A. H., Damuka, N., Bashetti, N., Gollapelli, K. K., Krizan, I., Bhoopal, B., Miller, M., Jv, S. K., Whitlow, C. T., McClain, D., Ma, T., Jorgensen, M. J., & Solingapuram Sai, K. K. (2023). First GPR119 PET Imaging Ligand: Synthesis, Radiochemistry, and Preliminary Evaluations. Journal of Medicinal Chemistry, 66(13), 9120-9129. https://doi.org/10.1021/acs.jmedchem.3c00720
Vancouver
Bansode AH, Damuka N, Bashetti N, Gollapelli KK, Krizan I, Bhoopal B, et al. First GPR119 PET Imaging Ligand: Synthesis, Radiochemistry, and Preliminary Evaluations. Journal of Medicinal Chemistry. 2023;66(13):9120-9129. doi:10.1021/acs.jmedchem.3c00720
BibTeX
@article{Bansode2023,
author = {Bansode, Avinash H and Damuka, Naresh and Bashetti, Nagaraju and Gollapelli, Krishna Kumar and Krizan, Ivan and Bhoopal, Bhuvanachandra and Miller, Mack and Jv, Shanmukha Kumar and Whitlow, Christopher T and McClain, Donald and Ma, Tao and Jorgensen, Matthew J and Solingapuram Sai, Kiran Kumar},
title = {First GPR119 PET Imaging Ligand: Synthesis, Radiochemistry, and Preliminary Evaluations},
journal = {Journal of Medicinal Chemistry},
year = {2023},
volume = {66},
number = {13},
pages = {9120--9129},
doi = {10.1021/acs.jmedchem.3c00720}
}
EUVIMED